No insider purchase over the last 90 days. The latest, by 이태훈, was filed 11 Aug 2026.
Jeonjinbio Co., Ltd.: what insiders have been doing
Jeonjinbio Co., Ltd., classified in the Chemicals sector, is a listed company. Its insiders report their share dealings to DART (FSS). From 1 November 2025 to 1 November 2026, the disclosure feed for Jeonjinbio Co., Ltd. logged 8 filings by 2 insiders.
The flow runs one way only: 1 insider bought (6 purchases) and nobody sold on the market. The totals exclude 6 filings filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. On the buying side, the filings list 1 major shareholder and 1 chief executive among the declarants.
The latest purchase dates back some time: it was published 91 days ago, on 11 August 2026.
Compared with its exchange (2,655 companies, median 7 filings), a count of 8 filings is above the norm. Since 2021, the database holds 33 purchases and no sales by insiders of the company.
For comparison within the same sector, see the insider buying recorded at Symrise AG and Titan. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.
Who traded when
BuySaleTransparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- Other0DART
- Other0DART
- 10,000 sharesShareKRXDART:20260811000535Canonical exit: 9 Nov 2026 (T+90)
- 92,000 sharesShareKRXDART:20260728000366Canonical exit: 26 Oct 2026 (T+90)
- Other0DART
- ●Executives0DART
- 24,740 sharesShareKRXDART:20260615000175Canonical exit: 13 Sept 2026 (T+90)
- 24,740 sharesKRXDART:20260615000172Canonical exit: 13 Sept 2026 (T+90)
- 62,200 sharesKRXDART:20260605000315Canonical exit: 3 Sept 2026 (T+90)
- 62,200 sharesShareKRXDART:20260605000327Canonical exit: 3 Sept 2026 (T+90)
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- 0KRXDART:20240614000093
- ShareKRXDART:20240614000084Canonical exit: 6 Aug 2024 (T+90)
- 617 sharesKRXDART:20240607000341Canonical exit: 28 Aug 2024 (T+90)
- 617 sharesKRXDART:20240517000356Canonical exit: 7 Aug 2024 (T+90)
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
25 of 59 declarations
About Jeonjinbio Co., Ltd.
Jeonjin Biopharm is a company specializing in the chemical and materials sector. It is listed on the XKRX market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
